Home
>
National Drug Code (NDC)
>
NICORETTE
NICORETTE - 0135-0509-02 - (nicotine polacrilex)
Drug Information of NICORETTE
| Product NDC: | 0135-0509 |
| Proprietary Name: | NICORETTE |
| Non Proprietary Name: | nicotine polacrilex |
| Active Ingredient(s): | 4 mg/1 & nbsp; nicotine polacrilex |
| Administration Route(s): | ORAL |
| Dosage Form(s): | LOZENGE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of NICORETTE
| Product NDC: | 0135-0509 |
| Labeler Name: | GlaxoSmithKline Consumer Healthcare LP |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | NDA022360 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100301 |
Package Information of NICORETTE
| Package NDC: | 0135-0509-02 |
| Package Description: | 3 CONTAINER in 1 CARTON (0135-0509-02) > 27 LOZENGE in 1 CONTAINER |
NDC Information of NICORETTE
| NDC Code | 0135-0509-02 |
| Proprietary Name | NICORETTE |
| Package Description | 3 CONTAINER in 1 CARTON (0135-0509-02) > 27 LOZENGE in 1 CONTAINER |
| Product NDC | 0135-0509 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | nicotine polacrilex |
| Dosage Form Name | LOZENGE |
| Route Name | ORAL |
| Start Marketing Date | 20100301 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline Consumer Healthcare LP |
| Substance Name | NICOTINE |
| Strength Number | 4 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
